National Health Investors Inc (NYSE:NHI) Q4 2016 Sentiment

July 18, 2017 - By Adrian Mccoy

 National Health Investors Inc (NYSE:NHI)  Q4 2016 Sentiment

Sentiment for National Health Investors Inc (NYSE:NHI)

National Health Investors Inc (NYSE:NHI) institutional sentiment decreased to 1.09 in Q4 2016. Its down -0.14, from 1.23 in 2016Q3. The ratio turned negative, as 88 hedge funds started new and increased positions, while 81 sold and trimmed stakes in National Health Investors Inc. The hedge funds in our partner’s database now possess: 26.67 million shares, down from 27.83 million shares in 2016Q3. Also, the number of hedge funds holding National Health Investors Inc in their top 10 positions increased from 0 to 1 for an increase of 1. Sold All: 22 Reduced: 59 Increased: 66 New Position: 22.

National Health Investors, Inc. is a self-managed real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The company has market cap of $3.13 billion. The Firm is engaged in the business of owning and financing healthcare properties. It has a 18.87 P/E ratio. The Company’s portfolio consists of lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals and medical office buildings.

It closed at $77.77 lastly. It is down 15.23% since July 18, 2016 and is uptrending. It has underperformed by 1.47% the S&P500.

Presima Inc. holds 5.28% of its portfolio in National Health Investors Inc for 480,300 shares. Lee Danner & Bass Inc owns 188,310 shares or 1.64% of their US portfolio. Moreover, Pinnacle Financial Partners Inc has 0.45% invested in the company for 27,995 shares. The Massachusetts-based Btim Corp. has invested 0.34% in the stock. Ironbridge Capital Management Lp, a Illinois-based fund reported 81,956 shares.#img1#

National Health Investors Inc (NYSE:NHI) Ratings Coverage

Ratings analysis reveals 50% of National Health Investors’s analysts are positive. Out of 6 Wall Street analysts rating National Health Investors, 3 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $59 while the high is $84. The stock’s average target of $70.17 is -9.77% below today’s ($77.77) share price. NHI was included in 10 notes of analysts from August 7, 2015. The firm has “Buy” rating by Stifel Nicolaus given on Monday, November 9. Zacks upgraded it to “Buy” rating and $66 target in Tuesday, September 22 report. BMO Capital Markets downgraded the shares of NHI in report on Wednesday, August 12 to “Market Perform” rating. Bank of America downgraded the stock to “Neutral” rating in Wednesday, August 12 report. As per Friday, March 11, the company rating was upgraded by Bank of America. The firm has “Buy” rating given on Thursday, September 3 by Zacks. The firm has “Overweight” rating by Stephens given on Wednesday, September 14.

More notable recent National Health Investors Inc (NYSE:NHI) news were published by: Seekingalpha.com which released: “Will National Health Investors Become A Consolidator?” on June 28, 2017, also Fool.com with their article: “Better Buy: Welltower Inc. vs. National Health Investors Inc.” published on January 10, 2017, Nasdaq.com published: “National Health Investors, Inc. (NHI) Ex-Dividend Date Scheduled for June 28, 2017” on June 27, 2017. More interesting news about National Health Investors Inc (NYSE:NHI) were released by: Seekingalpha.com and their article: “National Health Investors’ (NHI) CEO Eric Mendelsohn on Q1 2017 Results …” published on May 09, 2017 as well as Twst.com‘s news article titled: “National Health Investors Inc.: NHI Announces Second Quarter 2017 Earnings …” with publication date: July 17, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.